USCA RIA’s Novo Nordisk NVO Stock Holding History

USCA RIA’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$570K	Sell	13,608 -964	-7%	-$37.4K	0.03%	377
2021 Q1	$491K	Buy	14,572 +432	+3%	+$15.4K	0.03%	383
2020 Q4	$494K	Sell	14,140 -6,056	-30%	-$209K	0.03%	326
2020 Q3	$701K	Hold	20,196	–	–	0.06%	244
2020 Q2	$661K	Buy	20,196 +342	+2%	+$10.9K	0.06%	249
2020 Q1	$598K	Buy	19,854 +2,616	+15%	+$77.9K	0.07%	245
2019 Q4	$499K	Buy	17,238 +168	+1%	+$4.65K	0.04%	321
2019 Q3	$441K	Sell	17,070 -70	-0.4%	-$1.77K	0.04%	322
2019 Q2	$437K	Buy	17,140 +736	+4%	+$18.2K	0.04%	317
2019 Q1	$429K	Sell	16,404 -152	-0.9%	-$3.74K	0.05%	295
2018 Q4	$381K	Buy	16,556 +1,754	+12%	+$39K	0.05%	294
2018 Q3	$349K	Buy	14,802 +2,200	+17%	+$53.7K	0.04%	366
2018 Q2	$291K	Hold	12,602	–	–	0.03%	378
2018 Q1	$310K	Buy	12,602 +3,002	+31%	+$78.8K	0.03%	365
2017 Q4	$258K	Buy	+9,600	New	+$244K	0.03%	381

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

USCA RIA's NVO Position: Q2 2021 in Review

USCA RIA reduced its Novo Nordisk (NVO) stake by 6.6% in Q2 2021, selling an estimated $37.4K and leaving 13,608 shares worth $570K. The position accounts for 0.03% of the portfolio, ranked #377.

USCA RIA first reported a position in NVO in Q4 2017 and has held it in 15 quarters since. The position peaked at $701K in Q3 2020. 735 funds tracked by Wall St. Rank hold NVO as of Q2 2021.

USCA RIA held 13,608 shares of Novo Nordisk worth $570K as of Q2 2021.
USCA RIA sold 964 Novo Nordisk shares in Q2 2021, an estimated $37.4K.
Novo Nordisk made up 0.03% of USCA RIA's portfolio in Q2 2021, its #377 holding.
USCA RIA first reported a position in Novo Nordisk in Q4 2017 and has held it in 15 quarters since.
USCA RIA's Novo Nordisk position peaked at $701K in Q3 2020.
735 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.